Concerning the latter ones, different autoimmune diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), multiple sclerosis (MS), autoimmune thyroid diseases, Addison's disease, and T1D, are associated with an enhanced tissue expression of CXCL10, not only with increased circulating levels [81–85]. Here, CXCL10 is linked to systemic sclerosis.